OKT3/antithymocyte globulin immunoprophylaxis in the prevention of recurrence of acute vanishing bile duct syndrome in retransplanted patients.
Gómez
R
R
Department of General and Digestive Surgery, University Hospital 12 de Octubre, Madrid, Spain.
Moreno
E
E
Colina
F
F
Gonzalez
I
I
Loinaz
C
C
Garcia
I
I
Luque
I
I
Lumbreras
C
C
Vega
V
V
Moreno
C
C
D000208:Acute Disease; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001649:Bile Duct Diseases / Q000517:prevention & control*; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000517:prevention & control* / Q000628:therapy; D006801:Humans; D015994:Incidence; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000453:epidemiology; D012008:Recurrence; D012086:Reoperation; D013577:Syndrome; D013997:Time Factors
D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D008775:Methylprednisolone